Today: 21 May 2026
Browse Category

NASDAQ:BLDR 11 January 2026 - 12 January 2026

Builders FirstSource stock jumps 12% as Trump’s mortgage-bond push rewires the housing trade

Builders FirstSource stock jumps 12% as Trump’s mortgage-bond push rewires the housing trade

Builders FirstSource closed up 12% at $124.66 Friday after President Trump ordered $200 billion in mortgage-bond purchases to push down rates. The 30-year fixed mortgage rate fell below 6% for the first time in nearly three years, according to Redfin. Housing starts data were mixed, and investors are watching Tuesday’s U.S. CPI report for the next signal on rates.
12 January 2026
···

Stock Market Today

  • Sensex climbs 627 points, Nifty 50 surpasses 23,800 on easing West Asia tensions
    May 21, 2026, 12:38 AM EDT. The Indian stock market surged with the Sensex rising 627 points (0.83%) to 75,945.79 and the Nifty 50 advancing 200 points (0.85%) to 23,859.90. Gains followed reduced tensions in West Asia. Leading the rally were shares of IndiGo, Bharat Electronics Ltd (BEL), and Tata Steel, benefiting investor sentiment. The Nifty 50 index, a benchmark comprising 50 major stocks, reclaimed the 23,800 mark, signaling renewed market confidence amid easing geopolitical risks.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop